Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT04766177
Clinical Trial
Role of Bumetanide in Treatment of Autism
Recruiting
Phase 3
View on ClinicalTrials.gov →
Summary
Role of bumetanide in Autism
Trial Details
NCT Number
NCT04766177
Lead Sponsor
Sherief Abd-Elsalam
Conditions
Autism
Enrollment
80 participants
Start Date
2021-01-01
Primary Completion
2030-12-01
(estimated)
Study Completion
2030-12-01
(estimated)
Updated on ClinicalTrials.gov
2021-02-23